2020 IWGDF指南:糖尿病足的诊断

2020-01-20 国际糖尿病足工作组 Diabetes Metab Res Rev. 2020 Jan 20:e3276.

2020年1月,国际糖尿病足工作组(IWGDF)更新了糖尿病足的诊断指南,该指南是对之前IWGDF糖尿病足指南的更新,作为IWGDF糖尿病足病预防和管理指南的一部分,主要目的是针对糖尿病足溃疡和糖尿病患者外周动脉疾病的诊断,预后以及管理提出循证建议。

中文标题:

2020 IWGDF指南:糖尿病足的诊断

英文标题:

Guidelines of the international writing group on the diabetic foot on diagnosis.

发布机构:

国际糖尿病足工作组

发布日期:

2020-01-20

简要介绍:

2020年1月,国际糖尿病足工作组(IWGDF)更新了糖尿病足的诊断指南,该指南是对之前IWGDF糖尿病足指南的更新,作为IWGDF糖尿病足病预防和管理指南的一部分,主要目的是针对糖尿病足溃疡和糖尿病患者外周动脉疾病的诊断,预后以及管理提出循证建议。

 

拓展指南:糖尿病足相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 IWGDF指南:糖尿病足的诊断)] GetToolGuiderByIdResponse(projectId=1, id=5f0b51c0018552f8, title=2020 IWGDF指南:糖尿病足的诊断, enTitle=Guidelines of the international writing group on the diabetic foot on diagnosis., guiderFrom=Diabetes Metab Res Rev. 2020 Jan 20:e3276., authorId=null, author=, summary=2020年1月,国际糖尿病足工作组(IWGDF)更新了糖尿病足的诊断指南,该指南是对之前IWGDF糖尿病足指南的更新,作为IWGDF糖尿病足病预防和管理指南的一部分,主要目的是针对糖尿病足溃疡和糖尿病患者外周动脉疾病的诊断,预后以及管理提出循证建议。 , cover=, journalId=null, articlesId=null, associationId=449, associationName=国际糖尿病足工作组, associationIntro=关注糖尿病足治疗、诊断、感染分类系统, copyright=0, guiderPublishedTime=Mon Jan 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月,国际糖尿病足工作组(IWGDF)更新了糖尿病足的诊断指南,该指南是对之前IWGDF糖尿病足指南的更新,作为IWGDF糖尿病足病预防和管理指南的一部分,主要目的是针对糖尿病足溃疡和糖尿病患者外周动脉疾病的诊断,预后以及管理提出循证建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>糖尿病足</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=6ada41c001839005" title="中西医结合防治糖尿病足中国专家共识(第1版)" target=_blank>中西医结合防治糖尿病足中国专家共识(第1版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=6c0791c00180a3a5" title="2019《国际糖尿病足疾病预防和管理指南》解读" target=_blank>2019《国际糖尿病足疾病预防和管理指南》解读</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=843771c001e915a3" title="糖尿病足病医学营养治疗指南" target=_blank>糖尿病足病医学营养治疗指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c0be21c001e83574" title="中国糖尿病足防治指南(2019版)(V)" target=_blank>中国糖尿病足防治指南(2019版)(V)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=9d6ea1c001e633fb" title="中国糖尿病足防治指南(2019版)(Ⅳ)" target=_blank>中国糖尿病足防治指南(2019版)(Ⅳ)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E7%B3%96%E5%B0%BF%E7%97%85%E8%B6%B3" target=_blank>有关糖尿病足更多指南</a></ul>, tagList=[TagDto(tagId=329, tagName=糖尿病足)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7425, appHits=431, showAppHits=8, pcHits=3277, showPcHits=5984, likes=50, shares=14, comments=7, approvalStatus=1, publishedTime=Mon Jan 27 19:31:02 CST 2020, publishedTimeString=2020-01-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Jan 27 19:31:02 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:18:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 IWGDF指南:糖尿病足的诊断)])
2020 IWGDF指南:糖尿病足的诊断
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1063591, encodeId=3fa710635915b, content=临床收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3695145754, createdName=14686cb7m10暂无昵称, createdTime=Sun Oct 24 22:19:29 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062591, encodeId=6379106259158, content=实用性强,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=594e1932857, createdName=zljmed2015, createdTime=Thu Oct 21 14:35:29 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057809, encodeId=1d1d105e80902, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:17 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908653, encodeId=196490865333, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48315397608, createdName=ms7000000178049994, createdTime=Wed Dec 16 18:51:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893912, encodeId=253589391251, content=希望有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12cadff7m06暂无昵称, createdTime=Fri Oct 23 09:30:46 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-10-24 14686cb7m10暂无昵称

    临床收益

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1063591, encodeId=3fa710635915b, content=临床收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3695145754, createdName=14686cb7m10暂无昵称, createdTime=Sun Oct 24 22:19:29 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062591, encodeId=6379106259158, content=实用性强,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=594e1932857, createdName=zljmed2015, createdTime=Thu Oct 21 14:35:29 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057809, encodeId=1d1d105e80902, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:17 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908653, encodeId=196490865333, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48315397608, createdName=ms7000000178049994, createdTime=Wed Dec 16 18:51:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893912, encodeId=253589391251, content=希望有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12cadff7m06暂无昵称, createdTime=Fri Oct 23 09:30:46 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-10-21 zljmed2015

    实用性强,感谢!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1063591, encodeId=3fa710635915b, content=临床收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3695145754, createdName=14686cb7m10暂无昵称, createdTime=Sun Oct 24 22:19:29 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062591, encodeId=6379106259158, content=实用性强,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=594e1932857, createdName=zljmed2015, createdTime=Thu Oct 21 14:35:29 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057809, encodeId=1d1d105e80902, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:17 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908653, encodeId=196490865333, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48315397608, createdName=ms7000000178049994, createdTime=Wed Dec 16 18:51:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893912, encodeId=253589391251, content=希望有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12cadff7m06暂无昵称, createdTime=Fri Oct 23 09:30:46 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2021-10-05 H8888888

    受益匪浅

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1063591, encodeId=3fa710635915b, content=临床收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3695145754, createdName=14686cb7m10暂无昵称, createdTime=Sun Oct 24 22:19:29 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062591, encodeId=6379106259158, content=实用性强,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=594e1932857, createdName=zljmed2015, createdTime=Thu Oct 21 14:35:29 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057809, encodeId=1d1d105e80902, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:17 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908653, encodeId=196490865333, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48315397608, createdName=ms7000000178049994, createdTime=Wed Dec 16 18:51:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893912, encodeId=253589391251, content=希望有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12cadff7m06暂无昵称, createdTime=Fri Oct 23 09:30:46 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-12-16 ms7000000178049994

    有没有中文版的

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1063591, encodeId=3fa710635915b, content=临床收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b3695145754, createdName=14686cb7m10暂无昵称, createdTime=Sun Oct 24 22:19:29 CST 2021, time=2021-10-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1062591, encodeId=6379106259158, content=实用性强,感谢!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=594e1932857, createdName=zljmed2015, createdTime=Thu Oct 21 14:35:29 CST 2021, time=2021-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057809, encodeId=1d1d105e80902, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Tue Oct 05 10:31:17 CST 2021, time=2021-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908653, encodeId=196490865333, content=有没有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48315397608, createdName=ms7000000178049994, createdTime=Wed Dec 16 18:51:08 CST 2020, time=2020-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893912, encodeId=253589391251, content=希望有中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6943234878, createdName=12cadff7m06暂无昵称, createdTime=Fri Oct 23 09:30:46 CST 2020, time=2020-10-23, status=1, ipAttribution=)]
    2020-10-23 12cadff7m06暂无昵称

    希望有中文版的

    0